Prepubertal diagnosis of steroid 5 alpha-reductase deficiency. 1978

P Saenger, and A S Goldman, and L S Levine, and S Korth-Schutz, and E C Muecke, and M Katsumata, and Y Doberne, and M I New

The diagnosis of 5 alpha-reductase deficiency was proven in two prepubertal patients with male pseudohermaphroditism (MPH). Both had a 46-XY karyotype and were reared as females; one child had been castrated in infancy. Clitoromegaly, urogenital sinus, and short vaginal pouch were present in both; inguinal gonads were palpable in one. The diagnosis was made biochemically by observing characteristic changes in five parameters: 1) abnormally high testosterone to dihydrotestosterone (T:DHT) ratio after hCG stimulation (35 and 53 vs. normal, 11 +/- 3), 2) abnormally high 5 beta-T metabolites in urine (8.1 and 6.0 vs. normal, less than 1),3) deficient conversion of T to DHT during [3H] T infusion (0.3 and 0.4% vs. normal, 5.3 +/- 3), 4) deficient conversion of [14 C] T to 5 alpha-reduced metabolites by nongenital skin fibroblasts (2.2 and 1.9 pmol/microgram DNA/nmol substrate vs. 68.4+/- 7.8 Pmol/microgram DNA/nmol substrate in normal controls), and 5) deficient conversion of [14C]T to DHT in genital skin slices. The fact that this syndrome represents a defect in T metabolism rather in in T binding is demonstrated by the observation that binding of [3H]DHT to cytosol of skin fibroblasts was normal (4.2 dpm/micrograms DNA vs. normal male values of 3.7 +/- 0.64). Thus, the present report suggests that 5 alpha-reductase deficiency can be diagnosed during childhood and even after castration by metabolic studies of nongenital skin fibroblasts and determination of the conversion ratio of [3H]T to [3H]DHT in plasma.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D011627 Puberty A period in the human life in which the development of the hypothalamic-pituitary-gonadal system takes place and reaches full maturity. The onset of synchronized endocrine events in puberty lead to the capacity for reproduction (FERTILITY), development of secondary SEX CHARACTERISTICS, and other changes seen in ADOLESCENT DEVELOPMENT. Puberties
D002369 Castration Surgical removal or artificial destruction of gonads. Gonadectomy,Castrations,Gonadectomies
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast

Related Publications

P Saenger, and A S Goldman, and L S Levine, and S Korth-Schutz, and E C Muecke, and M Katsumata, and Y Doberne, and M I New
October 1993, Endocrine reviews,
P Saenger, and A S Goldman, and L S Levine, and S Korth-Schutz, and E C Muecke, and M Katsumata, and Y Doberne, and M I New
August 2006, Pediatric endocrinology reviews : PER,
P Saenger, and A S Goldman, and L S Levine, and S Korth-Schutz, and E C Muecke, and M Katsumata, and Y Doberne, and M I New
September 1992, The Journal of clinical investigation,
P Saenger, and A S Goldman, and L S Levine, and S Korth-Schutz, and E C Muecke, and M Katsumata, and Y Doberne, and M I New
February 1977, The American journal of medicine,
P Saenger, and A S Goldman, and L S Levine, and S Korth-Schutz, and E C Muecke, and M Katsumata, and Y Doberne, and M I New
January 1986, Hormone research,
P Saenger, and A S Goldman, and L S Levine, and S Korth-Schutz, and E C Muecke, and M Katsumata, and Y Doberne, and M I New
July 1994, Ginekologia polska,
P Saenger, and A S Goldman, and L S Levine, and S Korth-Schutz, and E C Muecke, and M Katsumata, and Y Doberne, and M I New
January 1994, Current therapy in endocrinology and metabolism,
P Saenger, and A S Goldman, and L S Levine, and S Korth-Schutz, and E C Muecke, and M Katsumata, and Y Doberne, and M I New
January 1993, Ryoikibetsu shokogun shirizu,
P Saenger, and A S Goldman, and L S Levine, and S Korth-Schutz, and E C Muecke, and M Katsumata, and Y Doberne, and M I New
June 1992, Archives of disease in childhood,
P Saenger, and A S Goldman, and L S Levine, and S Korth-Schutz, and E C Muecke, and M Katsumata, and Y Doberne, and M I New
December 1986, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!